Phreesia Named to the 2026 Capterra Shortlist for Appointment Scheduling

Phreesia, an innovator in patient intake, outreach, and engagement, has earned a spot on the prestigious 2026 Capterra Shortlist for Appointment Scheduling. This recognition highlights the company's commitment to enhancing the healthcare experience through technology. The Capterra Shortlist is curated based on a unique evaluation of user ratings and popularity metrics, showcasing leading products in the software industry.

In 2025, Phreesia was acknowledged in four categories, including Patient Engagement, underscoring its broad impact across the healthcare sector. Chaim Indig, CEO of Phreesia, emphasized the importance of this acknowledgment, noting that it stems from genuine feedback from users who depend on their solutions. This feedback reflects Phreesia's critical role in helping both patients and healthcare organizations streamline scheduling processes and operate more efficiently.

Phreesia boasts an impressive overall rating of 4.3 out of 5 on Capterra, garnered from 166 user reviews. The platform's ranking is determined through the analysis of verified user experiences and search data, which measure product visibility and popularity over time.

Founded in 2005, Phreesia has made significant strides in the healthcare field, facilitating approximately 170 million patient visits in 2024 alone—accounting for one in seven visits in the United States. This scale enables Phreesia to make meaningful impacts on healthcare delivery.

By providing patient-driven digital solutions for intake, outreach, and education, Phreesia aims to enhance patient experiences and improve healthcare outcomes. For more details on their offerings, visit www.phreesia.com. Overall, Phreesia's recognition by Capterra solidifies its reputation as a leader committed to empowering patients and health providers alike.

Phreesia’s recent recognition on the 2026 Capterra Shortlist for Appointment Scheduling underscores its growing prominence in the healthcare technology sector. Having previously secured multiple listings in 2025, this accolade further affirms Phreesia's robust standing among competitors. With an overall rating of 4.3 out of 5 based on 166 user reviews, the positive feedback highlights customer satisfaction, a vital metric for investors evaluating software companies.

Phreesia focuses on patient activation, providing an essential service in an era where healthcare efficiency and patient experience are paramount. Given the trend towards digitalization in the healthcare sector, the demand for appointment scheduling solutions is expected to rise. Phreesia's tools facilitate seamless patient interaction, making it easier for individuals to manage their healthcare needs, which is much appreciated by both patients and healthcare organizations. This places Phreesia strategically at the intersection of two burgeoning markets: telehealth and patient engagement.

Investors might consider Phreesia's potential for scalability, having handled approximately 170 million patient visits in 2024. This scale not only enhances its market influence but also enables Phreesia to generate valuable insights into patient behaviors and preferences, providing a competitive edge against smaller firms.

Moreover, recognition from industry authorities like Capterra can enhance Phreesia’s visibility and credibility in market segments, potentially attracting new partnerships and customers. However, as with any investment, due diligence is advisable. Keep an eye on industry trends, competitive movements, and Phreesia’s ability to innovate its offerings to maintain its market traction.

In summary, Phreesia’s recent accolades combined with its positioning in a growing market create a favorable outlook, making it a company to watch for potential investment opportunities in the healthcare technology space.